F. Gilbert McMahon

6.0k citations

112 papers · 4.8k indexed · 1 hit paper · h-index 29

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 9
- Inflammatory mediators and NSAID effects 9
- Pharmacology and Obesity Treatment 7
Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 9
- Inflammatory mediators and NSAID effects 9
- Pharmacology and Obesity Treatment 7
Toxicology top 1%
Anesthesiology and Pain Medicine top 2%
Endocrinology, Diabetes and Metabolism top 2%
- Hormonal Regulation and Hypertension 6
Cardiology and Cardiovascular Medicine
- Blood Pressure and Hypertension Studies 15
Pediatrics, Perinatology and Child Health
- Pharmaceutical studies and practices 10
Geriatrics and Gerontology
- Pharmaceutical Practices and Patient Outcomes 7
Analytical Chemistry
- Analytical Methods in Pharmaceuticals 5

Co-authors: Ramón Vargas Adesh K. Jain Jerome R. Ryan D E Duggan K.C. Kwan H. Donald Hochstein Anthony S. Ridolfo R Nickander
Cited by: Pharmacology Toxicology
Partner nations: United States Japan Switzerland

In The Last Decade

F. Gilbert McMahon

106 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by F. Gilbert McMahon

Since Specialization

Citations

This map shows the geographic impact of F. Gilbert McMahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Gilbert McMahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Gilbert McMahon more than expected).

Fields of papers citing papers by F. Gilbert McMahon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Gilbert McMahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Gilbert McMahon. The network helps show where F. Gilbert McMahon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside F. Gilbert McMahon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Gilbert McMahon Line = papers co-authored together F. Gilbert McMahon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Extended in Vivo Pharmacodynamic Activity of E5564 in Normal Volunteers with Experimental Endotoxemia Melvyn Lynn,Y. Nancy Wong,Janice L. Wheeler,Richard Kao,Carlos Perdomo,Robert J. Noveck,Ramón Vargas,Tony D’Angelo,Sandra Gotzkowsky,F. Gilbert McMahon,Kishor M. Wasan,Daniel P. Rossignol	2004	32
2	Blocking of Responses to Endotoxin by E5564 in Healthy Volunteers with Experimental Endotoxemia Melvyn Lynn,Daniel P. Rossignol,Janice L. Wheeler,Richard Kao,Carlos Perdomo,Robert J. Noveck,Ramón Vargas,Tony D’Angelo,Sandra Gotzkowsky,F. Gilbert McMahon	2003	127
3	Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors F. Gilbert McMahon,Samuel Weinstein,Everton Rowe,K Ernst,F. Johnson,Ken Fujioka	2002	73
4	Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by β-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial John J. Sramek,Mark Leibowitz,Samuel Weinstein,Everton Rowe,Carl M. Mendel,Brian Levy,F. Gilbert McMahon,William S. Mullican,Phillip D. Toth,Neal R. Cutler	2002	43
5	Dose‐Related Inflammatory Effects of Intravenous Endotoxin in Humans: Evaluation of a New Clinical Lot ofEscherichia coliO:113 Endotoxin Anthony F. Suffredini,H. Donald Hochstein,F. Gilbert McMahon	1999	130
6	Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee A. Weaver,Bernard Rubin,Jacques Caldwell,F. Gilbert McMahon,David Lee,William S. Makarowski,Howard Offenberg,Marshall Sack,David Sikes,Robert G. Trapp,Susan Rush,Michael E. Kuss,Jitendra Ganju,Tomás S. Bocanegra	1995	24
7	A Multicenter Comparison of the Safety and Efficacy of Isradipine and Enalapril in the Treatment of Hypertension Gilbert M. Eisner,Brian F. G. Johnson,F. Gilbert McMahon,Peter Rudd,James R. Sowers,Roberto Vargas,Michael B. Zemel	1991	10
8	Potassium Restoration in Hypertensive Patients Made Hypokalemic by Hydrochlorothiazide Harold W. Schnaper,E. D. Freis,R. Friedman,W. Thomas Garland,Wayne Hall,John W. Hollifield,P A Jenkins,Allan D. Marks,F. Gilbert McMahon,Nancy C. Sambol,R. L. Williams,Nathaniel Winer	1990	1
9	Some Problems With Antihypertensive Drug Studies in the Context of the New Guidelines Martin Rose,F. Gilbert McMahon	1990	67
10	Some socioeconomic factors in the selection of blood pressure drugs in New Orleans, Louisiana F. Gilbert McMahon,Andrew R. Johnson,W. Colin Duncan	1989	5
11	A double-blind study of ibuprofen 200 mg in combination with caffeine 100 mg, ibuprofen 400 mg, and placebo in episiotomy pain Anurag Jain,F. Gilbert McMahon,J. R. Ryan,C. Narcisse	1988	14
12	An Acute Dose‐Response Pharmacodynamic Evaluation of Orally Administered Isradipine (PN‐200‐110) in Hypertensive Patients F. Gilbert McMahon,Ramón Vargas,Jerome R. Ryan,Howard C. Miller,Susan Faraday	1988	4
13	A double-blind study of diflunisal and codeine compared with codeine or diflunisal alone in postoperative pain Adesh K. Jain,F. Gilbert McMahon,Jerome R. Ryan,Gladys Smith,Rayanne S. Berman	1988	5
14	Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension Michael F. Wilson,Olga M. Haring,Andrew Lewin,Glenn Bedsole,William Stepansky,John M. Fillingim,Dallas Hall,Martin S. Roginsky,F. Gilbert McMahon,Paul I. Jagger,Mark Strauss	1986	22
15	Comparison of Oral Nalbuphine, Acetaminophen, and Their Combination in Postoperative Pain Adesh K. Jain,Jerome R. Ryan,F. Gilbert McMahon,Gladys Smith	1986	12
16	Management of essential hypertension : the new low-dose era F. Gilbert McMahon	1984	26
17	Disulfiram-like reaction to a cephalospolin. F. Gilbert McMahon	1980	0
18	Points from Letters: Potential Toxicity of Slow-K F. Gilbert McMahon	1975	1
19	Evaluation of gastrointestinal, pulmonary, anti-inflammatory, and immunological agents F. Gilbert McMahon,Clinical Pharmacological Methods Phase	1974	1
20	Endocrine-Metabolic drugs F. Gilbert McMahon,Clinical Pharmacological Methods Phase	1974	0

About F. Gilbert McMahon

F. Gilbert McMahon is a scholar working on Pharmacology, Geriatrics and Gerontology and Pharmacology, having authored 112 papers that have together received 4.8k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (15 papers), Pharmaceutical studies and practices (10 papers), Pharmacogenetics and Drug Metabolism (9 papers), Inflammatory mediators and NSAID effects (9 papers), Pharmacology and Obesity Treatment (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers), Hormonal Regulation and Hypertension (6 papers) and Analytical Methods in Pharmaceuticals (5 papers). The work is most often cited by research in Pharmacology (1.2k citations), Pharmacology (408 citations) and Toxicology (133 citations). F. Gilbert McMahon has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Ramón Vargas, Adesh K. Jain, Jerome R. Ryan, D E Duggan, K.C. Kwan, H. Donald Hochstein, Anthony S. Ridolfo, R Nickander, Anthony F. Suffredini and Everton Rowe.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact